Total Payments
$4,482
2024 Payments
$616.31
Companies
29
Transactions
251
Medicare Patients
2,786
Medicare Billing
$451,153
Payment Breakdown by Category
Food & Beverage$4,482 (100.0%)
Gifts$0.01 (0.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,482 | 250 | 100.0% |
| Gift | $0.01 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $933.48 | 55 | $0 (2024) |
| ABBVIE INC. | $836.53 | 66 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $627.60 | 32 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $407.15 | 19 | $0 (2021) |
| SCILEX PHARMACEUTICALS INC. | $346.31 | 20 | $0 (2024) |
| Boston Scientific Corporation | $249.57 | 6 | $0 (2024) |
| Merck Sharp & Dohme LLC | $151.72 | 8 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $128.58 | 9 | $0 (2022) |
| Almatica Pharma LLC | $127.81 | 5 | $0 (2023) |
| Medtronic, Inc. | $86.88 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $616.31 | 33 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($191.94) |
| 2023 | $856.08 | 44 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($264.59) |
| 2022 | $1,607 | 101 | ABBVIE INC. ($381.68) |
| 2021 | $1,402 | 73 | Biohaven Pharmaceuticals, Inc. ($407.15) |
All Payment Transactions
251 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: Gastroenterology | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Gastroenterology | ||||||
| 10/29/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $5.41 | General |
| Category: Gastroenterology | ||||||
| 10/07/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $43.46 | General |
| 10/01/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $42.37 | General |
| 09/26/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.44 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $19.19 | General |
| Category: Pain management | ||||||
| 09/05/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Analgesic | ||||||
| 08/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.97 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Gastroenterology | ||||||
| 08/01/2024 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Orthopedic | ||||||
| 07/10/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Gastroenterology | ||||||
| 07/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Gastroenterology | ||||||
| 06/03/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 05/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: NEUROSCIENCE | ||||||
| 05/07/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Analgesic | ||||||
| 05/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $11.11 | General |
| Category: Gastroenterology | ||||||
| 04/19/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: NEUROSCIENCE | ||||||
| 04/12/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $18.60 | General |
| Category: Opioid Analgesic | ||||||
| 04/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: Gastroenterology | ||||||
| 04/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Gastroenterology | ||||||
| 03/30/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: NEUROSCIENCE | ||||||
| 03/29/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 1,405 | 2,530 | $954,140 | $215,474 |
| 2022 | 6 | 757 | 1,650 | $687,889 | $127,174 |
| 2021 | 4 | 624 | 1,407 | $593,754 | $108,505 |
Total Patients
2,786
Total Services
5,587
Medicare Billing
$451,153
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 491 | 1,229 | $567,486 | $100,995 | 17.8% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 293 | 408 | $122,400 | $62,612 | 51.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 322 | 556 | $196,824 | $32,625 | 16.6% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 198 | 235 | $29,375 | $14,312 | 48.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $23,895 | $2,503 | 10.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 15 | $11,160 | $1,687 | 15.1% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 59 | 60 | $3,000 | $741.00 | 24.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 329 | 1,054 | $486,948 | $81,286 | 16.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 172 | 322 | $113,988 | $18,635 | 16.3% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 82 | 86 | $25,800 | $13,198 | 51.2% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 123 | 137 | $17,125 | $8,343 | 48.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 39 | 39 | $35,100 | $4,187 | 11.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 12 | $8,928 | $1,525 | 17.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 334 | 881 | $407,022 | $76,400 | 18.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 248 | 483 | $170,982 | $29,867 | 17.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 16 | 16 | $14,400 | $1,910 | 13.3% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2021 | 26 | 27 | $1,350 | $328.41 | 24.3% |
About Benjamin Pearce, NP
Benjamin Pearce, NP is a Nurse Practitioner healthcare provider based in Folsom, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/07/2020. The National Provider Identifier (NPI) number assigned to this provider is 1548882012.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Benjamin Pearce, NP has received a total of $4,482 in payments from pharmaceutical and medical device companies, with $616.31 received in 2024. These payments were reported across 251 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($4,482).
As a Medicare-enrolled provider, Pearce has provided services to 2,786 Medicare beneficiaries, totaling 5,587 services with total Medicare billing of $451,153. Data is available for 3 years (2021–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Folsom, CA
- Active Since 05/07/2020
- Last Updated 05/24/2024
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1548882012
Products in Payments
- RELISTOR (Drug) $933.48
- XTAMPZA (Drug) $590.67
- NURTEC ODT (Drug) $582.25
- QULIPTA (Drug) $421.29
- UBRELVY (Drug) $362.01
- ZTLido (Drug) $228.46
- BELSOMRA (Drug) $151.72
- GRALISE (Drug) $127.81
- BELBUCA (Drug) $73.60
- INTELLIS ADAPTIVESTIM (Device) $68.50
- Aimovig (Biological) $64.01
- INFINION (Device) $58.89
- Infinion 16 (Device) $54.22
- Qutenza (Drug) $52.74
- PROLATE (Drug) $46.30
- Belbuca (Drug) $36.93
- BOTOX (Biological) $34.00
- Xeomin (Biological) $33.25
- Superion Indirect Decompression System (Device) $33.01
- QUTENZA (Drug) $29.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Folsom
Sean Koulaboud, Aprn, APRN
Nurse Practitioner — Payments: $2,373
Nurse Practitioner $2,373
Jasleen Agroia, Np, NP
Nurse Practitioner — Payments: $1,649
Nurse Practitioner $1,649
Jaya George, Np, NP
Nurse Practitioner — Payments: $733.26
Nurse Practitioner $733.26
Laura Galindo, Np, NP
Nurse Practitioner — Payments: $418.83
Nurse Practitioner $418.83
Pamela Visathep, Fnp, FNP
Nurse Practitioner — Payments: $159.46
Nurse Practitioner $159.46
Katherine Slugocki, Np, NP
Nurse Practitioner — Payments: $96.30
Nurse Practitioner $96.30